GlassScriptPhysician profile
Jennifer Woiwode
NPI 1437795796
$2,447.24
in general payments reported to CMS, 2019-2025
15 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $575 · 2022: $616 · 2023: $516 · 2024: $636 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,245 · Education: $12.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,244.76 |
| Education | $12.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $509.19 | 2021-2024 | Caplyta |
| Alkermes, INC. | $409.55 | 2021-2024 | Aristada, Lybalvi |
| Lundbeck LLC | $386.57 | 2021-2024 | Rexulti |
| Abbvie INC. | $325.47 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $278.69 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $172.69 | 2022-2024 | Uzedy, Austedo Xr, Austedo |
| Takeda Pharmaceuticals U.S.A., INC. | $98.46 | 2021-2023 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $66.40 | 2021-2024 | Rexulti |
| Axsome Therapeutics, INC. | $53.14 | 2023-2024 | Auvelity |
| Neurocrine Biosciences, INC. | $39.85 | 2023-2024 | Ingrezza |
| Acadia Pharmaceuticals INC | $29.79 | 2022 | |
| Sage Therapeutics, LLC | $29.64 | 2024 | |
| Supernus Pharmaceuticals, INC. | $22.05 | 2025 | Qelbree |
| Jazz Pharmaceuticals INC. | $13.41 | 2022 | |
| Allergan, INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Woiwode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.